Cas no 635712-44-6 (5-Bromo-7-chloro-1H-indazole)

5-Bromo-7-chloro-1H-indazole is a halogenated indazole derivative with significant utility in pharmaceutical and agrochemical research. Its bromo and chloro substituents enhance reactivity, making it a versatile intermediate for synthesizing biologically active compounds. The indazole core structure is known for its stability and ability to interact with various biological targets, contributing to applications in drug discovery, particularly in kinase inhibition and antimicrobial development. The compound's well-defined molecular structure allows for precise modifications, facilitating the exploration of structure-activity relationships. High purity and consistent quality ensure reliable performance in synthetic applications, supporting its use in advanced organic and medicinal chemistry research.
5-Bromo-7-chloro-1H-indazole structure
5-Bromo-7-chloro-1H-indazole structure
Product Name:5-Bromo-7-chloro-1H-indazole
CAS No:635712-44-6
MF:C7H4BrClN2
MW:231.477059364319
MDL:MFCD11044588
CID:68521
PubChem ID:21102194
Update Time:2025-05-19

5-Bromo-7-chloro-1H-indazole Chemical and Physical Properties

Names and Identifiers

    • 5-Bromo-7-chloro-1H-indazole
    • 1H-Indazole, 5-bromo-7-chloro-
    • 1H-Indazole,5-bromo-7-chloro
    • 5-BROMO-7-CHLOROINDAZOLE
    • PubChem20591
    • 1H-Indazole,5-bromo-7-chloro-
    • IQSRPQLSDHXAIZ-UHFFFAOYSA-N
    • BCP27204
    • INDAZOLE, 5-BROMO-7-CHLORO-
    • MB09125
    • FCH1401857
    • RP08941
    • BC004575
    • BC257481
    • ST1100648
    • AX8103013
    • AB0031017
    • X3335
    • A8752
    • 4
    • AC-28249
    • FT-0649442
    • AMY24482
    • CS-0041815
    • SCHEMBL3601695
    • SY025378
    • Z1269130417
    • DS-12811
    • EN300-3215626
    • J-517141
    • DTXSID70610771
    • MFCD11044588
    • AKOS005258442
    • 635712-44-6
    • MDL: MFCD11044588
    • Inchi: 1S/C7H4BrClN2/c8-5-1-4-3-10-11-7(4)6(9)2-5/h1-3H,(H,10,11)
    • InChI Key: IQSRPQLSDHXAIZ-UHFFFAOYSA-N
    • SMILES: BrC1C=C(C2=C(C=NN2)C=1)Cl

Computed Properties

  • Exact Mass: 229.92500
  • Monoisotopic Mass: 229.925
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 1
  • Heavy Atom Count: 11
  • Rotatable Bond Count: 0
  • Complexity: 155
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 3.3
  • Topological Polar Surface Area: 28.7

Experimental Properties

  • Density: 1.878
  • Melting Point: ca 205℃
  • Boiling Point: 364.1°C at 760 mmHg
  • Flash Point: 364.1 °C at 760 mmHg
  • Refractive Index: 1.73
  • PSA: 28.68000
  • LogP: 2.97880

5-Bromo-7-chloro-1H-indazole Security Information

5-Bromo-7-chloro-1H-indazole Customs Data

  • HS CODE:2933990090
  • Customs Data:

    China Customs Code:

    2933990090

    Overview:

    2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date

    Summary:

    2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

5-Bromo-7-chloro-1H-indazole Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
SHANG HAI XIAN DING Biotechnology Co., Ltd.
GJ096-250mg
5-Bromo-7-chloro-1H-indazole
635712-44-6 97%
250mg
736CNY 2021-05-08
SHANG HAI XIAN DING Biotechnology Co., Ltd.
GJ096-1g
5-Bromo-7-chloro-1H-indazole
635712-44-6 97%
1g
1842CNY 2021-05-08
SHANG HAI XIAN DING Biotechnology Co., Ltd.
GJ096-10g
5-Bromo-7-chloro-1H-indazole
635712-44-6 97%
10g
9510CNY 2021-05-08
SHANG HAI XIAN DING Biotechnology Co., Ltd.
GJ096-100mg
5-Bromo-7-chloro-1H-indazole
635712-44-6 97%
100mg
491CNY 2021-05-08
SHANG HAI XIAN DING Biotechnology Co., Ltd.
GJ096-5g
5-Bromo-7-chloro-1H-indazole
635712-44-6 97%
5g
5696CNY 2021-05-08
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
45R0397-1g
5-Bromo-7-chloro-1H-indazole
635712-44-6 96%
1g
1272.06CNY 2021-05-08
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
45R0397-5g
5-Bromo-7-chloro-1H-indazole
635712-44-6 96%
5g
3816.19CNY 2021-05-08
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
45R0397-25g
5-Bromo-7-chloro-1H-indazole
635712-44-6 96%
25g
12720.64CNY 2021-05-08
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
45R0397-500mg
5-Bromo-7-chloro-1H-indazole
635712-44-6 96%
500mg
1060.05CNY 2021-05-08
JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd.
45R0397-250mg
5-Bromo-7-chloro-1H-indazole
635712-44-6 96%
250mg
924.37CNY 2021-05-08

5-Bromo-7-chloro-1H-indazole Production Method

Additional information on 5-Bromo-7-chloro-1H-indazole

5-Bromo-7-chloro-1H-indazole (CAS No. 635712-44-6): A Comprehensive Overview

5-Bromo-7-chloro-1H-indazole (CAS No. 635712-44-6) is a heterocyclic organic compound belonging to the indazole family. This compound has gained significant attention in pharmaceutical and materials science research due to its unique structural features and potential applications. The presence of both bromo and chloro substituents on the indazole ring makes it a valuable intermediate for further chemical modifications.

The molecular formula of 5-Bromo-7-chloro-1H-indazole is C7H4BrClN2, with a molecular weight of 231.48 g/mol. Its structure consists of a fused benzene and pyrazole ring system, with bromine and chlorine atoms at the 5 and 7 positions, respectively. This specific substitution pattern contributes to the compound's electronic properties and reactivity, making it particularly interesting for medicinal chemistry applications.

Recent studies have highlighted the importance of halogenated indazole derivatives in drug discovery. The 5-Bromo-7-chloro-1H-indazole scaffold serves as a key building block for the synthesis of various biologically active compounds. Researchers are particularly interested in its potential applications in developing kinase inhibitors, which are crucial for treating various diseases. The compound's ability to participate in diverse chemical reactions makes it a versatile intermediate in organic synthesis.

From a synthetic chemistry perspective, 5-Bromo-7-chloro-1H-indazole offers several advantages. The presence of both halogen atoms allows for selective functionalization through cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings. These transformations enable the creation of more complex molecular architectures that are valuable in pharmaceutical research. The compound's stability under various reaction conditions further enhances its utility as a synthetic intermediate.

The pharmaceutical industry has shown growing interest in indazole-based compounds due to their diverse biological activities. 5-Bromo-7-chloro-1H-indazole serves as a precursor for molecules with potential therapeutic applications in areas such as oncology, neurology, and inflammation. Researchers are actively investigating its derivatives as potential drug candidates, particularly focusing on their interactions with various biological targets.

In materials science, halogenated indazoles like 5-Bromo-7-chloro-1H-indazole have found applications in the development of organic electronic materials. The electron-withdrawing nature of the halogen substituents influences the compound's electronic properties, making it suitable for use in organic semiconductors or as a component in light-emitting materials. These applications align with current trends in sustainable and organic electronics.

The analytical characterization of 5-Bromo-7-chloro-1H-indazole typically involves techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and high-performance liquid chromatography (HPLC). These methods ensure the compound's purity and confirm its structural identity, which is crucial for research and industrial applications. The compound generally appears as a white to off-white crystalline powder with good stability under standard storage conditions.

Market trends indicate increasing demand for specialized indazole derivatives like 5-Bromo-7-chloro-1H-indazole. Pharmaceutical and biotechnology companies are actively sourcing high-quality intermediates for their drug discovery programs. The compound's commercial availability from specialized chemical suppliers has made it more accessible to researchers worldwide, facilitating advancements in various scientific fields.

Safety considerations for handling 5-Bromo-7-chloro-1H-indazole follow standard laboratory practices for organic compounds. While not classified as hazardous under normal circumstances, proper personal protective equipment should be used when working with this chemical. Researchers should consult the material safety data sheet (MSDS) for specific handling and storage recommendations to ensure safe laboratory practices.

Future research directions for 5-Bromo-7-chloro-1H-indazole include exploring its potential in green chemistry applications and developing more efficient synthetic routes. The compound's versatility makes it a promising candidate for various innovative applications in medicinal chemistry and materials science. As research continues, we can expect to see new discoveries leveraging this interesting molecular scaffold.

For researchers interested in halogenated heterocycles or pharmaceutical intermediates, 5-Bromo-7-chloro-1H-indazole represents an important compound with diverse applications. Its unique structural features and reactivity profile continue to make it a valuable tool in modern chemical research and drug development efforts across multiple disciplines.

Recommended suppliers
上海帛亦醫(yī)藥科技有限公司
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Tiancheng Chemical (Jiangsu) Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Jing Kun Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Jing Kun Chemical Co.,Ltd.